Leishmania is not prone to develop resistance to tamoxifen

por Coelho, Adriano C., Trinconi, Cristiana T., Senra, Luisa, Yokoyama-Yasunaka, Jenicer K.U., Uliana, Silvia R.B.
Publicado 2015

Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania

por Trinconi, Cristiana T., Miguel, Danilo C., Silber, Ariel M., Brown, Christopher, Mina, John G.M., Denny, Paul W., Heise, Norton, Uliana, Silvia R.B.
Publicado 2018

Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome()()

por Ribeiro, Camila Sampaio, França, Riam Rocha, Silva, Juliana Almeida, Silva, Silvana Conceição da, Uliana, Sílvia R.B., Boaventura, Viviane Sampaio, Machado, Paulo R.L.
Publicado 2021

Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake

por Espada, Caroline R., Magalhães, Rubens M., Cruz, Mario C., Machado, Paulo R., Schriefer, Albert, Carvalho, Edgar M., Hornillos, Valentín, Alves, João M., Cruz, Angela K., Coelho, Adriano C., Uliana, Silvia R.B.
Publicado 2019

A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient

por Zauli, Rogéria C, Yokoyama-Yasunaka, Jenicer KU, Miguel, Danilo C, Moura, Alexandre S, Pereira, Ledice IA, da Silva, Ildefonso A, Lemes, Lucianna GN, Dorta, Miriam L, de Oliveira, Milton AP, Pitaluga, André N, Ishikawa, Edna AY, Rodrigues, Juliany CF, Traub-Cseko, Yara M, Bijovsky, A Tania, Ribeiro-Dias, Fátima, Uliana, Silvia RB
Publicado 2012